Top Buy
| Security | Buy ▼ | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Celldex Therapeutics | 11 | 1 | 2 | 0 | €37.00 | €56.62 | 53.019% |
| iRhythm Technologies Inc | 11 | 0 | 1 | 0 | €86.50 | €123.46 | 42.723% |
| Laboratory Corp. Of America (labcorp) | 11 | 0 | 2 | 0 | €197.00 | €237.94 | 20.782% |
| Heron Therapeutics Inc. | 11 | 1 | 4 | 0 | €3.11 | €4.59 | 47.746% |
| Gilead Sciences Inc | 11 | 1 | 3 | 0 | €62.46 | €84.81 | 35.786% |
| Corcept Therapeutics Inc. | 11 | 0 | 3 | 0 | €26.89 | €35.43 | 31.756% |
| Chromadex Corp | 11 | 1 | 1 | 0 | €3.04 | €5.58 | 83.414% |
| Rigel Pharmaceutical Inc. | 10 | 0 | 1 | 0 | €0.88 | €13.77 | 1462.450% |
| Cara Therapeutics Inc. | 10 | 1 | 2 | 0 | €0.73 | €4.62 | 530.464% |
| Teleflex Inc. | 10 | 0 | 0 | 0 | €202.00 | €247.18 | 22.366% |
| Verastem Inc. | 10 | 0 | 1 | 0 | €10.60 | €24.63 | 132.404% |
| Charles River Labs Intl | 10 | 0 | 1 | 0 | €204.40 | €248.57 | 21.610% |
| Bio-Techne Corp. | 10 | 0 | 2 | 0 | €76.50 | €75.94 | -0.737% |
| Xencor Inc. | 10 | 1 | 1 | 0 | €22.60 | €32.58 | 44.154% |
| Universal Health Services B | 10 | 3 | 1 | 0 | €166.00 | €161.53 | -2.693% |
| Medpace Holdings Inc | 9 | 0 | 3 | 0 | €367.60 | €421.61 | 14.691% |
| Medtronic plc | 9 | 1 | 0 | 0 | €78.05 | €93.46 | 19.738% |
| Biocryst Pharmaceuticals | 9 | 0 | 2 | 0 | €5.68 | €11.05 | 94.630% |
| Radnet Inc. | 9 | 3 | 2 | 0 | €54.00 | €54.58 | 1.075% |
| Axonics Modulation Technologies Inc | 9 | 0 | 0 | 0 | €58.50 | €66.53 | 13.724% |
| Ensign Group Inc. | 9 | 0 | 2 | 0 | €110.00 | €116.99 | 6.357% |
| BeiGene Ltd ADR | 9 | 1 | 2 | 0 | €160.00 | €241.54 | 50.965% |
| LivaNova plc | 9 | 0 | 3 | 0 | €56.00 | €66.59 | 18.916% |
| QIAGEN NV | 9 | 0 | 0 | 0 | €40.47 | €47.44 | 17.223% |
| Evolus Inc | 9 | 0 | 3 | 0 | €12.10 | €20.43 | 68.864% |